Chemotherapy plus panitumumab/cetuximab versus chemotherapy plus bevacizumab in wild-type KRAS/RAS metastatic colorectal cancer: a meta-analysis-Reference-Cited by-同舟云学术

Chemotherapy plus panitumumab/cetuximab versus chemotherapy plus bevacizumab in wild-type KRAS/RAS metastatic colorectal cancer: a meta-analysis

Author:

Zhang Chengren¹²³^ORCID,Liu Lili⁴^ORCID,Lv Yaochun²³,Li Jingjing¹²³,Cao Cong¹²³,Lu Jiyong²³⁴,Wang Shuai²³⁴,Du Binbin²³,Yang Xiongfei²³

Affiliation:

1. General Hospital of Ningxia Medical University

2. Department of Anorectal Surgery, Gansu Provincial People’s Hospital

3. Anorectal Disease Research Center, Gansu Provincial People’s Hospital

4. The First Clinical Medical College of Gansu University of Chinese Medicine

Funder

Scientific Research Fund of Gansu Provincial People’s Hospital

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

Reference52 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献